Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer
新型 VEGFR 抑制剂阿帕替尼治疗转移性三阴性乳腺癌多中心 II 期临床研究
期刊:International Journal of Cancer
影响因子:5.7
doi:10.1002/ijc.28829
Xichun Hu, Jian Zhang, Binghe Xu, Zefei Jiang, Joseph Ragaz, Zhongsheng Tong, Qingyuan Zhang, Xiaojia Wang, Jifeng Feng, Danmei Pang, Minhao Fan, Jin Li, Biyun Wang, Zhonghua Wang, Qunling Zhang, Si Sun, Chunmei Liao